Chandan Kumar
Associate Research Scientist
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (7)
Year:
2025
Year:
2025
Year:
2025
Purpose: Devimistat (CPI-613) is a novel inhibitor of tumoral mitochondrial metabolism. We investigated the effect of devimistat in vitro and in a phase Ib clinical trial in patients with advanced biliary tract cancer (BTC). Patients and Methods: Cell viability assays of devimistat ± gemcitabine and cisplatin (GC) were performed and the effect of devimistat on mitochondrial respiration via oxygen consumption rate (OCR) was evaluated. A phase Ib/II trial was initiated in patients with untreated advanced BTC. In phase Ib, devimistat was infused over 2 hours in combination with GC on days 1 and 8 every 21 days with a primary objective to determine the recommended phase II dose (RP2D). Secondary objectives included safety, overall response rate (ORR), progression-free survival (PFS), and overall survival (OS). Results: In vitro, devimistat with GC had a synergistic effect on two cell lines. Devimistat significantly decreased OCR at higher doses and in arms with divided dosing. In the phase Ib trial, 20 patients received a median of nine cycles (range, 3–19). One DLT was observed, and the RP2D of devimistat was determined to be 2,000 mg/m2 in combination with GC. Most common grade 3 toxicities included neutropenia (n = 11, 55%), anemia (n = 4, 20%), and infection (n = 3, 15%). There were no grade 4 toxicities. After a median follow-up of 15.6 months, ORR was 45% and median PFS was 10 months (95% confidence interval, 7.1–14.9). Median OS is not yet estimable. Conclusions: Devimistat in combination with GC is well tolerated and has an acceptable safety profile in patients with untreated advanced BTC.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (15)
Ute Scholl
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Tracy Ann Williams
-
Vaibhav Sahai
University of Michigan
Richard Warth
University of Regensburg
Jiaqi Shi
Professor
University of Michigan
Arathi Mohan
Clinical Assistant Professor
University of Michigan
Desmaré van Rooyen
Research Investigator
University of Michigan
Antonio Marcondes Lerario
University of Michigan
Carl Koschmann
University of Michigan Medical School
Michelle Jacobs
University of Michigan Medical School
Andrea T. Franson
-
Jamie Mills
Clinical Assistant Professor
University of Michigan
Timothy Frankel
Assistant Professor
University of Michigan Hospital
Bernt Popp
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Frederike Butz
Charité - Universitätsmedizin Berlin
Make your next move.
Prepare your application
Review drafts before you send them.